Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter

Search Results for: label/Nigeria vaccine measles meningitis

CEPI 3.0 and the Race to Develop the World’s First Lassa Fever Vaccine
Shalom David and Uwaifiokun Okhuarobo (Lead writers) Every dry season, the wards begin to fill. At Irrua Specialist Teaching Hospital in Edo State and the Federal Medical Centre in Owo,…
When Children Miss Vaccines, Polio Risks Re-emerge: Lessons from Kebbi State
Mahdi Garba (Lead writer) When Umar Adamu, the Disease Surveillance and Notification Officer (DSNO) for Aliero Local Government Area in Kebbi State, received a report of an 11-year-old girl in…
West Africa Takes Historic Step Toward Lassa Fever Vaccine Access with Launch of First End-to-End Roadmap
West Africa has today, 3rd February 2026, marked a major milestone in regional health security with the official launch of the Lassa Fever End-to-End (E2E) Access Roadmap for West Africa,…
CEPI backs updated Zaire ebolavirus vaccine that aims to improve vaccine affordability and accessibility for low- and middle-income countries
$30 million project seeks to overcome barriers to access and sustainability of MSD’s Zaire ebolavirus vaccine. Manufacturing process will be updated to make a vaccine that is intended to be less costly…
Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate
Serum Institute of India to make up to 100,000 investigational Oxford Rift Valley fever vaccine doses. Rift Valley fever is a potentially deadly viral disease currently affecting West Africa. Doses…
First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial
The Oxford Vaccine Group has vaccinated the first volunteer in a first-in-human trial of a Lassa vaccine The CEPI-funded trial is being conducted in Oxford, with a second phase 1…
Encouraging results from a first-in-human Phase 1 clinical trial of IAVI’s Lassa vaccine candidate published in New England Journal of Medicine
One dose elicits robust and long-lasting immune responses in healthy adults in the U.S. and Liberia Key takeaways: IAVI’s Lassa vaccine candidate rVSVΔG-LASV-GPC has an acceptable safety profile and elicits…
West Africa Unite in Abidjan to Fast-Track Lassa Fever Vaccine and Strengthen Epidemic Preparedness
The 2nd ECOWAS Lassa Fever International Conference (#ELFIC 2025) concluded this Thursday 11 September 2025 in Abidjan, Côte d’Ivoire, after four days of high-level discussions, knowledge sharing, and strategic commitments.…
West African Health Ministers Unite for Lassa Fever Vaccine Readiness: A Historic Step for Regional Health Security
Uwaifiokun Okhuarobo (Lead writer) The ECOWAS Lassa International Conference builds on the first convening held in Abuja in 2019, when the country came together to mark fifty years since the…
West African Leaders Commit to Advance Lassa Fever Vaccine For the Region
In an historic moment for regional solidarity and leadership, West African Ministers of Health pledge their joint commitment to advance the development of, and readiness for, much-needed vaccines against Lassa…